High blood Pressure Animations – Medical Animations

Viagra's Other Talents: To Help A 'Signaling' Protein Shield The Heart From High Blood Pressure Damage
Johns Hopkins and other researchers report what is believed to be the first direct evidence in lab animals that the erectile dysfunction drug sildenafil amplifies the effects of a heart-protective protein. The team's findings, to be published in the Journal of Clinical Investigation online Jan.

New High Blood Pressure Gene Discovered
Using genome-wide association for the first time to scan for genes implicated in high blood pressure, and studying both Amish and non-Amish people, US scientists have discovered a gene involved in regulating how kidneys process salt whose variant they suggest is linked to high blood pressure risk.

NicOx' Naproxcinod Shows Differentiated 24-Hour Blood Pressure Profile After 13 Weeks Treatment
NicOx S.A. (Euronext Paris: COX) announced positive results from the 112 clinical pharmacology study in 299 patients with osteoarthritis (OA) and hypertension, which was designed to characterize the 24-hour blood pressure profile of naproxcinod in comparison to the two most widely used non-steroidal anti-inflammatory drugs (NSAIDs). At week 13, naproxcinod 750 mg bid showed a reduction in systolic blood pressure (SBP) of 2.7 mmHg compared to naproxen 500 mg bid and 3.

Pre-Eclampsia Risk Increased By Miscarriage And Infertility Treatment
Repeated miscarriages and hormone treatment for infertility give an increased risk of pre-eclampsia among pregnant women. This comes from a new study from the Norwegian Institute of Public Health. More than 20 000 first-time mothers from the Norwegian Mother and Child Cohort Study (MoBa) were included in the study. Normal risk First-time mothers who had not miscarried or had problems getting pregnant had a 5.2 % risk of pre-eclampsia.

'Soccer And Health' Research Funded By F-MARC
It's fun, healthy and practicable to play soccer, shows research from the Department of Exercise and Sport Sciences, University of Copenhagen. The project has received international attention and in 2008 F-MARC (Medical Assessment and Research Centre of FIFA) co-funded a series of follow-up projects examining health benefits of football and jogging for young and middle-aged men and women with hypertension and other life style-related diseases.

Preeclampsia Test To Reduce Maternal And Neonatal Deaths
A new technology that could help physicians screen pregnant women at risk of developing a prenatal and potentially fatal complication called preeclampsia has been developed at The University of Western Ontario and the Children's Health Research Institute of Lawson Health Research Institute. The technology, employing a panel of biomarkers found to have changed levels in the placenta of women who develop preeclampsia, has been licensed to California-based Biosite Inc.

NicOx' Naproxcinod Shows Robust Blood Pressure Results In Phase 3 Pooled Analysis
NicOx S.A. (NYSE Euronext Paris: COX) announced positive results of a pre-specified pooled analysis of 2,734 patients with osteoarthritis (OA) from the 301, 302 and 303 pivotal phase 3 studies for naproxcinod. Both doses of naproxcinod showed a significant reduction in systolic and diastolic blood pressure (SBP and DBP) compared to naproxen 500 mg bid over the whole 13 week period (p

Cognitive Function May Be Affected By High Blood Pressure In The Elderly
Adding another reason for people to watch their blood pressure, a new study from North Carolina State University shows that increased blood pressure in older adults is directly related to decreased cognitive functioning, particularly among seniors with already high blood pressure. This means that stressful situations may make it more difficult for some seniors to think clearly. Dr.

Soliris(R) Reduced Markers Of Thrombosis, Inflammation, And Decreased Indicators Of Pulmonary Hypertension, In Patients With PNH
Soliris® (eculizumab), a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN), reduced blood measures associated with undiagnosed dangerous blood clots and inflammation in patients with PNH, providing support of possible anti-thrombotic properties of Soliris in patients with PNH.

Elevated Central Blood Pressure In Young African American Men - Noninvasive Technology May Cardiovascular Risk Earlier
AtCor Medical (ASX: ACG), the developer and marketer of the SphygmoCor(R) system, which measures central blood pressures and arterial stiffness noninvasively, today responded to media reports on a study* available online in the American Journal of Physiology, published by the American Physiological Society.

Soliris(R) Reduced Measures Of Thrombosis And Inflammation, And Decreased Indicators Of Pulmonary Hypertension, In Studies Of Patients With PNH
Soliris(R) (eculizumab), a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN), was observed by investigators to reduce blood measures associated with undiagnosed blood clots and inflammation in patients with PNH. A separate study found that Soliris was observed to reduce indicators of pulmonary artery hypertension (PAH) in patients with paroxysmal nocturnal hemoglobinuria (PNH), according to a new analysis of clinical trial data.

Population Study Finds Genetic Clues
A new genome-wide study examines genetic variants associated with nine metabolic traits and is the first to draw out novel variants from a population unselected for current disease. The traits are indicators for common disease such as cardiovascular disease, type 2 diabetes, blood pressure, inflammation and lipid levels.

Mediterranean Diet Plus Nuts May Be Helpful In Managing Metabolic Syndrome
A traditional Mediterranean diet with an additional daily serving of mixed nuts appears to be useful for managing some metabolic abnormalities in older adults at high risk for heart disease, according to a report in the December 8/22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Blood Pressure Measured In Doctor's Office May Not Adequately Predict Heart Risks
Blood pressure, as measured in a medical office, does not seem to predict future heart risks, in comparison with continuous blood pressure monitoring in individuals with treatment-resistant hypertension, according to an article released on November 24, 2008 in Archives of Internal Medicine, on of the JAMA/Archives journals.

MU Researcher Develops Screening Tool To Identify Patients With Prediabetes
A third of Americans with diabetes do not know that they have it, and many more who have prediabetic conditions are unaware that they are at risk. A University of Missouri researcher has created a clinical tool to identify those at highest risk for having undetected hyperglycemia, impaired fasting glucose (IFG) and undiagnosed diabetes.